Correlation Between Defence Therapeutics and Oxford Nanopore

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and Oxford Nanopore at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and Oxford Nanopore into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Defence Therapeutics and Oxford Nanopore Technologies, you can compare the effects of market volatilities on Defence Therapeutics and Oxford Nanopore and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of Oxford Nanopore. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and Oxford Nanopore.

Diversification Opportunities for Defence Therapeutics and Oxford Nanopore

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Defence and Oxford is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and Oxford Nanopore Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oxford Nanopore Tech and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with Oxford Nanopore. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oxford Nanopore Tech has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and Oxford Nanopore go up and down completely randomly.

Pair Corralation between Defence Therapeutics and Oxford Nanopore

Assuming the 90 days horizon Defence Therapeutics is expected to under-perform the Oxford Nanopore. In addition to that, Defence Therapeutics is 1.15 times more volatile than Oxford Nanopore Technologies. It trades about -0.07 of its total potential returns per unit of risk. Oxford Nanopore Technologies is currently generating about -0.01 per unit of volatility. If you would invest  303.00  in Oxford Nanopore Technologies on September 12, 2024 and sell it today you would lose (108.00) from holding Oxford Nanopore Technologies or give up 35.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Defence Therapeutics  vs.  Oxford Nanopore Technologies

 Performance 
       Timeline  
Defence Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Defence Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Oxford Nanopore Tech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Oxford Nanopore Technologies are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Oxford Nanopore reported solid returns over the last few months and may actually be approaching a breakup point.

Defence Therapeutics and Oxford Nanopore Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Defence Therapeutics and Oxford Nanopore

The main advantage of trading using opposite Defence Therapeutics and Oxford Nanopore positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, Oxford Nanopore can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oxford Nanopore will offset losses from the drop in Oxford Nanopore's long position.
The idea behind Defence Therapeutics and Oxford Nanopore Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk